Nuvo Research Inc (NRIFF) 5.5300 $NRIFF Nuvo Ph
Post# of 273240
Posted On: 09/26/2016 1:14:07 AM
Nuvo Research Inc (NRIFF) 5.5300 $NRIFF
Nuvo Pharmaceuticals™ Inc. Appoints New Chief Financial Officer
PR Newswire - Thu Sep 01, 3:30PM CDT
Nuvo Pharmaceuticals Inc. (TSX: NRI), (Nuvo or the Company), a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that Mary-Jane Burkett, has been appointed by its board of directors to the position of Vice President and Chief Financial Officer. Ms. Burkett joined Nuvo in 2012 and most recently was its Corporate Controller. She is a Chartered Professional Accountant and holds an Honours Bachelor of Business Administration Degree from the Ivey Business School, University of Western Ontario. Ms. Burkett replaces Stephen Lemieux who has resigned to pursue other opportunities.
NRI.TO: 7.45 (+0.35), HZNP: 19.43 (+0.02)
Nuvo Pharmaceuticals(TM) Inc. Appoints New Chief Financial Officer
CNW Group - Thu Sep 01, 3:30PM CDT
Nuvo Pharmaceuticals Inc. (TSX: NRI), (Nuvo or the Company), a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that Mary-Jane Burkett, has been appointed by its board of directors to the position of Vice President and Chief Financial Officer. Ms. Burkett joined Nuvo in 2012 and most recently was its Corporate Controller. She is a Chartered Professional Accountant and holds an Honours Bachelor of Business Administration Degree from the Ivey Business School, University of Western Ontario. Ms. Burkett replaces Stephen Lemieux who has resigned to pursue other opportunities.
NRI.TO: 7.45 (+0.35), HZNP: 19.43 (+0.02)
Nuvo Pharmaceuticals™ Announces 2016 Second Quarter Results
PR Newswire - Wed Aug 10, 4:00PM CDT
Q2 net income increases to $2.5 million or $0.22 basic earnings per share - - Positive cash from operating activities of $2.1 million in the quarter -
NRI.TO: 7.45 (+0.35), HZNP: 19.43 (+0.02)
Nuvo Pharmaceuticals(TM) Announces 2016 Second Quarter Results
CNW Group - Wed Aug 10, 4:00PM CDT
- Q2 net income increases to $2.5 million or $0.22 basic earnings per share -- Positive cash from operating activities of $2.1 million in the quarter -
NRI.TO: 7.45 (+0.35), HZNP: 19.43 (+0.02)
Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting
PR Newswire - Tue Jun 07, 2:42PM CDT
Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI) a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that at its 2016 Annual Meeting of Shareholders held in Toronto, all nominees listed in the management proxy circular dated May 4, 2016 were elected as directors of the Company.
NRI.TO: 7.45 (+0.35), HZNP: 19.43 (+0.02)
Nuvo Pharmaceuticals(TM) Announces Director Election Results of its Annual General Meeting
CNW Group - Tue Jun 07, 2:42PM CDT
Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI) a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that at its 2016 Annual Meeting of Shareholders held in Toronto, all nominees listed in the management proxy circular dated May 4, 2016 were elected as directors of the Company.
NRI.TO: 7.45 (+0.35), HZNP: 19.43 (+0.02)
Nuvo Pharmaceuticals™ Announces 2016 First Quarter Results
PR Newswire - Wed May 11, 4:00PM CDT
Revenue and gross margin increase - - Nuvo to Host Conference Call/Audio Webcast May 12th at 8:30 a.m. ET -
NRI.TO: 7.45 (+0.35), HZNP: 19.43 (+0.02)
Nuvo Pharmaceuticals™ Inc. Appoints New Chief Financial Officer
PR Newswire - Thu Sep 01, 3:30PM CDT
Nuvo Pharmaceuticals Inc. (TSX: NRI), (Nuvo or the Company), a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that Mary-Jane Burkett, has been appointed by its board of directors to the position of Vice President and Chief Financial Officer. Ms. Burkett joined Nuvo in 2012 and most recently was its Corporate Controller. She is a Chartered Professional Accountant and holds an Honours Bachelor of Business Administration Degree from the Ivey Business School, University of Western Ontario. Ms. Burkett replaces Stephen Lemieux who has resigned to pursue other opportunities.
NRI.TO: 7.45 (+0.35), HZNP: 19.43 (+0.02)
Nuvo Pharmaceuticals(TM) Inc. Appoints New Chief Financial Officer
CNW Group - Thu Sep 01, 3:30PM CDT
Nuvo Pharmaceuticals Inc. (TSX: NRI), (Nuvo or the Company), a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that Mary-Jane Burkett, has been appointed by its board of directors to the position of Vice President and Chief Financial Officer. Ms. Burkett joined Nuvo in 2012 and most recently was its Corporate Controller. She is a Chartered Professional Accountant and holds an Honours Bachelor of Business Administration Degree from the Ivey Business School, University of Western Ontario. Ms. Burkett replaces Stephen Lemieux who has resigned to pursue other opportunities.
NRI.TO: 7.45 (+0.35), HZNP: 19.43 (+0.02)
Nuvo Pharmaceuticals™ Announces 2016 Second Quarter Results
PR Newswire - Wed Aug 10, 4:00PM CDT
Q2 net income increases to $2.5 million or $0.22 basic earnings per share - - Positive cash from operating activities of $2.1 million in the quarter -
NRI.TO: 7.45 (+0.35), HZNP: 19.43 (+0.02)
Nuvo Pharmaceuticals(TM) Announces 2016 Second Quarter Results
CNW Group - Wed Aug 10, 4:00PM CDT
- Q2 net income increases to $2.5 million or $0.22 basic earnings per share -- Positive cash from operating activities of $2.1 million in the quarter -
NRI.TO: 7.45 (+0.35), HZNP: 19.43 (+0.02)
Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting
PR Newswire - Tue Jun 07, 2:42PM CDT
Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI) a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that at its 2016 Annual Meeting of Shareholders held in Toronto, all nominees listed in the management proxy circular dated May 4, 2016 were elected as directors of the Company.
NRI.TO: 7.45 (+0.35), HZNP: 19.43 (+0.02)
Nuvo Pharmaceuticals(TM) Announces Director Election Results of its Annual General Meeting
CNW Group - Tue Jun 07, 2:42PM CDT
Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI) a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that at its 2016 Annual Meeting of Shareholders held in Toronto, all nominees listed in the management proxy circular dated May 4, 2016 were elected as directors of the Company.
NRI.TO: 7.45 (+0.35), HZNP: 19.43 (+0.02)
Nuvo Pharmaceuticals™ Announces 2016 First Quarter Results
PR Newswire - Wed May 11, 4:00PM CDT
Revenue and gross margin increase - - Nuvo to Host Conference Call/Audio Webcast May 12th at 8:30 a.m. ET -
NRI.TO: 7.45 (+0.35), HZNP: 19.43 (+0.02)
(0)
(0)Scroll down for more posts ▼